PRAME anticorps (AA 1-509) (FITC)
-
- Antigène Voir toutes PRAME Anticorps
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
-
Épitope
- AA 1-509
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRAME est conjugé à/à la FITC
- Application
- Veuillez nous consulter SVP
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Melanoma antigen preferentially expressed in tumors protein (1-509AA)
- Isotype
- IgG
- Top Product
- Discover our top product PRAME Anticorps primaire
-
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 416-502) antibody
PRAME Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 151-250) antibodyPRAME Reactivité: Humain, Souris ELISA, FACS, IF (cc), IF (p), ICC, IHC (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-509) antibodyPRAME Reactivité: Humain WB, IP, IF Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-509) antibodyPRAME Reactivité: Humain ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 476-502), (C-Term) antibodyPRAME Reactivité: Humain WB, FACS, IHC (p) Hôte: Lapin Polyclonal RB18763 unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-509) antibodyPRAME Reactivité: Humain WB Hôte: Souris Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-200) antibodyPRAME Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 460-510) antibodyPRAME Reactivité: Humain, Boeuf (Vache), Cheval, Singe, Chien WB Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 71-120) antibodyPRAME Reactivité: Humain, Cheval, Porc, Lapin WB Hôte: Lapin Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (N-Term) antibodyPRAME Reactivité: Humain, Rat, Boeuf (Vache), Porc, Singe WB Hôte: Lapin Polyclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
- Autre désignation
- PRAME (PRAME Produits)
- Synonymes
- anticorps PRAME, anticorps CT130, anticorps MAPE, anticorps OIP-4, anticorps OIP4, anticorps 4930534P07Rik, anticorps preferentially expressed antigen in melanoma, anticorps PRAME, anticorps Prame
- Sujet
-
Background: Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. Prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis.
Aliases: 4930534P07Rik antibody, Cancer/testis antigen 130 antibody, CT130 antibody, MAPE antibody, Melanoma antigen preferentially expressed in tumors antibody, OIP 4 antibody, OIP-4 antibody, OIP4 antibody, OPA interacting protein 4 antibody, Opa interacting protein OIP4 antibody, OPA-interacting protein 4 antibody, PRAME antibody, PRAME_HUMAN antibody, Preferentially expressed antigen in melanoma antibody, Preferentially expressed antigen of melanoma antibody, RP23-250F8.3 antibody
- UniProt
- P78395
- Pathways
- Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
-
